Exploiting genetic complexity in cancer to improve therapeutic strategies.

Drug Discovery Today
Mathew J Garnett, Ultan McDermott

Abstract

Advances in genome sequencing technologies are enabling researchers to make rapid progress in defining the entire repertoire of causal genetic changes in cancer. The response of patients with cancer to therapy is often highly variable and there is an increasing number of examples where mutations in cancer genomes have been shown to have a profound effect on the clinical effectiveness of drugs. An urgent challenge for the research and clinical communities is how to translate these genomic data sets into new and improved therapeutic strategies for the treatment of patients. The use of large-scale cell line-based drug screens to identify genomic 'biomarkers' of drug response for the stratification of patients has the potential to transform how patients with cancer are treated.

References

Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Apr 5, 2001·The New England Journal of Medicine·B J DrukerC L Sawyers
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerUNKNOWN IRIS Investigators
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ultan McDermottJeffrey Settleman
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Mar 26, 2011·Science·Michael R Stratton
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group

❮ Previous
Next ❯

Citations

Dec 29, 2012·Molecular Cancer Therapeutics·Stefan HartJeanette M Wood
Jul 16, 2015·International Journal of Cancer. Journal International Du Cancer·Grace ChanRichard H Weisbart
Apr 8, 2016·Cell Reports·Constance Qiao Xin YeoChit Fang Cheok
Oct 1, 2013·Drug Discovery Today. Therapeutic Strategies·Lee Spraggon, Luca Cartegni
Apr 21, 2012·Cancer Cell·Paul WorkmanBissan Al-Lazikani
Dec 12, 2012·Cancer Discovery·David C Loch, Pamela M Pollock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.